Pulmonary embolism: Difference between revisions
Kashish Goel (talk | contribs) |
Kashish Goel (talk | contribs) |
||
| Line 44: | Line 44: | ||
===Medical Therapy:=== | ===Medical Therapy:=== | ||
:*'''[[Pulmonary embolism medical therapy|Anticoagulation]]:''' [[Pulmonary embolism medical therapy#Heparin|Unfractionated | :*'''[[Pulmonary embolism medical therapy|Anticoagulation]]:''' [[Pulmonary embolism medical therapy#Heparin|Unfractionated Heparin]] | [[Pulmonary embolism medical therapy#Low molecular weight heparin|Low molecular weight heparin]] | [[Pulmonary embolism medical therapy#Factor Xa Inhibitor|Factor Xa inhibitor]] | [[Pulmonary embolism medical therapy#Direct thrombin inhibitors|Direct thrombin inhibitor]] | [[Pulmonary embolism medical therapy#Warfarin|Warfarin]] | ||
:*'''Fibrinolytic:''' [[Pulmonary embolism treatment thrombolysis|Thrombolysis]] | :*'''Fibrinolytic:''' [[Pulmonary embolism treatment thrombolysis|Thrombolysis]] | ||
Revision as of 19:34, 22 May 2012
For patient information click here
| Pulmonary embolism | |
| ICD-10 | I26 |
|---|---|
| ICD-9 | 415.1 |
| DiseasesDB | 10956 |
| MedlinePlus | 000132 |
|
Pulmonary Embolism Microchapters |
|
Diagnosis |
|---|
|
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores |
|
Treatment |
|
Follow-Up |
|
Special Scenario |
|
Trials |
|
Case Studies |
|
Pulmonary embolism On the Web |
Editor(s)-In-Chief: The APEX Trial Investigators, C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Historical Perspective
Classification Scheme
I: Acute pulmonary embolism | Chronic pulmonary embolism
II: Massive pulmonary embolism | Submassive pulmonary embolism | Low-risk pulmonary embolism
Pathophysiology
Epidemiology and Demographics
Risk factors
Natural History, Complications & Prognosis
Differential Diagnosis
Pretest probability of PE
Wells Score | Original Geneva Score | Revised Geneva Score | Simplified Geneva Score | PE Rule-out Criteria | Summary of PE Clinical Probability based on Clinical Prediction Rules | ESC Guideline Recommendations
Diagnosis
History & Symptoms | Physical Examination | Laboratory Tests | Arterial Blood Gas | D-dimer | Biomarkers | Electrocardiogram | Chest x ray | Ventilation/Perfusion scan | Echocardiography | Compression Ultrasonography | Chest CT | CT Pulmonary Angiography (CTPA) | MRI
Treatment
Treatment Approach
Medical Therapy:
- Fibrinolytic: Thrombolysis
Surgery:
Guidelines
ACCP Guidelines
Initial treatment of Acute PE | Guidelines for Long-term treatment of PE | Chronic Thromboembolic Pulmonary Hypertension
ACC/AHA Guidelines
Guidelines for Initial Anticoagulation for Acute PE | Surgical embolectomy | Inferior vena cava filters | Iliofemoral DVT management guidelines | Compression therapy for DVT | Thromboreductive Strategies | Percutaneous Transluminal Venous Angioplasty and Stent Placement
ESC Guidelines
- Diagnosis: Suspected high-risk PE | Suspected non-high-risk PE | Low clinical probability | Intermediate clinical probability | High clinical probability
- Treatment: High-risk pulmonary embolism | Non-high-risk pulmonary embolism | Long-term treatment | Inferior vena cava filters | Thrombolysis
Discharge Care
Discharge Care | Follow-Up/Recurrence | Support group